Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | UNK | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | B5NJ9 | — |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
left side scalp sore; area behind left ear intermittent pain; left side of larynx sore; This spontaneous report was received from a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On 09-SEP-2025, the patient was vaccinated with a dose of (Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (dose, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On the same day, the patient was administered a dose of respiratory syncytial virus (RSV) vaccine (manufacturer: GlaxoSmithKline) (dose, route of administration, anatomical location, lot # and expiration date were not provided). On an unknown date in 2025, the patient experienced left side scalp sore, area behind left ear intermittent pain and left side of larynx sore. The outcome of area behind left ear intermittent pain and left side of larynx sore was reported as recovered. The outcome of left side scalp sore was considered as not recovered at the time of the report. Causality assessment was not provided. The patient tried to figure out if some of the symptoms experienced afterwards are from the suspect vaccines. Lot # is being requested and will be submitted if received.